Paper3136932
Retinoic acid upregulates interleukin-2 receptors on activated human thymocytes.
Sidell N and 1 other. Cell Immunol, 1988. Cited by 44 papers, by iCite.
Cite this record
ConductScience Library. Retinoic acid upregulates interleukin-2 receptors on activated human thymocytes. Papers, record 3136932. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/3136932
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics12
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Interleukin-2 | Major topic |
| Lymphocyte Activation | Major topic |
| Receptors, Immunologic | Major topic |
| T-Lymphocytes | Major topic |
| Tretinoin | Major topic |
| Cell Cycle | |
| Humans | |
| In Vitro Techniques | |
| Phytohemagglutinins | |
| Receptors, Interleukin-2 | |
| Recombinant Proteins | |
| Thymus Gland |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| CA30515 | NCI NIH HHS | United States | R01CA030515 | PubMed and NIH |
Source NIH RePORTER
Cited by7
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 44 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 16292516 | All-trans-retinoic acid suppresses interferon-gamma and tumor necrosis factor-alpha; a possible therapeutic agent for rheumatoid arthritis. | Rheumatol Int | 2006 | https://conductscience.org/library/papers/16292516 | PubMed |
| 10815802 | All-trans-retinoic acid upregulates TNF receptors and potentiates TNF-induced activation of nuclear factors-kappaB, activated protein-1 and apoptosis in human lung cancer cells. | Oncogene | 2000 | https://conductscience.org/library/papers/10815802 | PubMed |
| 9155646 | Retinol (vitamin A) is a cofactor in CD3-induced human T-lymphocyte activation. | Immunology | 1997 | https://conductscience.org/library/papers/9155646 | PubMed |
| 8734361 | The effects of retinoic acid on immunoglobulin synthesis: role of interleukin 6. | J Clin Immunol | 1996 | https://conductscience.org/library/papers/8734361 | PubMed |
| 8384693 | Transcription of retinoic acid receptor genes in transgenic mice increases CD8 T-cell subset. | Mol Biol Rep | 1993 | https://conductscience.org/library/papers/8384693 | PubMed |
| 8157276 | Transcriptional regulation by retinoic acid of interleukin-2 alpha receptors in human B cells. | Immunology | 1994 | https://conductscience.org/library/papers/8157276 | PubMed |
| 1918383 | Immunosuppressive activity of 13-cis-retinoic acid and prevention of experimental autoimmune encephalomyelitis in rats. | J Clin Invest | 1991 | https://conductscience.org/library/papers/1918383 | PubMed |
Genes2
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| IL2 | 3558 | PubTator's text mining | https://conductscience.org/library/genes/3558 | NCBI Gene |
| IL2RB | 3560 | PubTator's text mining | https://conductscience.org/library/genes/3560 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/3136932
GET https://conductscience.org/api/papers/v1/3136932/authors